BLC Stock Overview

BLC fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	4/6
Financial Health	5/6
Dividends	2/6

Rewards

Trading at 33.9% below our estimate of its fair value

Earnings grew by 21.9% over the past year

Risk Analysis

Does not have a meaningful market cap (THB3B)

Dividend of 3.18% is not well covered by free cash flows

My Notes

Capture your thoughts, links and company narrative

Bangkok Lab And Cosmetic Public Company Limited Competitors

T.Man Pharmaceutical

SET:TMAN

฿5.6b

JSP Pharmaceutical Manufacturing (Thailand) Public

SET:JSP

฿949.1m

Mega Lifesciences

SET:MEGA

฿29.4b

Sakar Healthcare

NSEI:SAKAR

₹6.6b

Price History & Performance

Summary of share price highs, lows and changes for Bangkok Lab And Cosmetic
Historical stock prices
Current Share Price	฿4.40
52 Week High	฿6.30
52 Week Low	฿4.36
Beta	0
1 Month Change	-17.76%
3 Month Change	-26.67%
1 Year Change	-6.78%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-38.89%

Recent updates

Shareholder Returns

	BLC	TH Pharmaceuticals	TH Market
7D	-6.4%	-1.2%	-4.7%
1Y	-6.8%	9.2%	-3.4%

Return vs Industry: BLC underperformed the TH Pharmaceuticals industry which returned 9.2% over the past year.

Return vs Market: BLC underperformed the TH Market which returned -3.4% over the past year.

Price Volatility

Is BLC's price volatile compared to industry and market?
BLC volatility
BLC Average Weekly Movement	4.2%
Pharmaceuticals Industry Average Movement	5.1%
Market Average Movement	4.3%
10% most volatile stocks in TH Market	8.9%
10% least volatile stocks in TH Market	2.1%

Stable Share Price: BLC has not had significant price volatility in the past 3 months compared to the TH market.

Volatility Over Time: BLC's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2022	n/a	Suvit Ngampoopun	bangkoklab.co.th

Bangkok Lab And Cosmetic Public Company Limited manufacturing and distributing of pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. The company distributes food supplements, cosmeceuticals, and pharmaceutical drugs; medicine, medical supplies, tonics, and supplements for animals; and supplementary food and herbs. It also engages in provision of management consulting and logistic services; and export of cosmeceuticals, pharmaceutical drugs, medicines, herbs, and cosmetics.

Bangkok Lab And Cosmetic Public Company Limited Fundamentals Summary

How do Bangkok Lab And Cosmetic's earnings and revenue compare to its market cap?
BLC fundamental statistics
Market cap	฿2.64b
Earnings (TTM)	฿166.85m
Revenue (TTM)	฿1.55b

15.8x

P/E Ratio

1.7x

P/S Ratio

Is BLC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BLC income statement (TTM)
Revenue	฿1.55b
Cost of Revenue	฿674.56m
Gross Profit	฿876.45m
Other Expenses	฿709.59m
Earnings	฿166.85m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.28
Gross Margin	56.51%
Net Profit Margin	10.76%
Debt/Equity Ratio	9.6%

How did BLC perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

47%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 09:18
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bangkok Lab And Cosmetic Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution